TMBR
Price:
$0.3426
Market Cap:
$1.18M
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to severe subtypes of CI, a group of rare genetic keratinization disorders; and TMB-002, a proprietary topical formulation of rapamycin, which is in Phase 2b clinical trial for the treatment of facial angiofibroma in tuberous sclerosis complex, a multisystem genetic disorder resulting in the growth of hamartomas in multiple organs. It is also involved in...[Read more]
Industry
Biotechnology
IPO Date
2014-09-08
Stock Exchange
AMEX
Ticker
TMBR
According to Timber Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.17. This represents a change of -65.51% compared to the average of -0.50 of the last 4 quarters.
The mean historical PE Ratio of Timber Pharmaceuticals, Inc. over the last ten years is -516214.60. The current -0.17 PE Ratio has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), TMBR's PE Ratio was at its highest in in the December 2020 quarter at 6.03. The PE Ratio was at its lowest in in the July 2017 quarter at -25588169.71.
Average
-516214.60
Median
-1.22
Minimum
-5162129.09
Maximum
0
Discovering the peaks and valleys of Timber Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 680.41%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -5162129.09
Year | PE Ratio | Change |
---|---|---|
2022 | -0.19 | -86.82% |
2021 | -1.44 | 87.19% |
2020 | -0.77 | -91.59% |
2020 | -9.17 | 680.41% |
2019 | -1.18 | -6.93% |
2018 | -1.26 | 33.57% |
2017 | -0.95 | -51.11% |
2016 | -1.93 | -Infinity% |
2014 | 0 | -100.00% |
2013 | -5162129.09 | -46.55% |
The current PE Ratio of Timber Pharmaceuticals, Inc. (TMBR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.80
5-year avg
-2.55
10-year avg
-516214.60
Timber Pharmaceuticals, Inc.’s PE Ratio is greater than Salarius Pharmaceuticals, Inc. (-0.39), greater than Artelo Biosciences, Inc. (-0.85), greater than Nutriband Inc. (-6.68), greater than Aileron Therapeutics, Inc. (-1.57), greater than Artelo Biosciences, Inc. (-0.85), less than Histogen Inc. (-0.01), greater than Curis, Inc. (-0.54), greater than First Wave BioPharma, Inc. (-0.37), greater than SAB Biotherapeutics, Inc. (-0.93), greater than Vaccinex, Inc. (-0.41), greater than GeoVax Labs, Inc. (-0.68), less than TRACON Pharmaceuticals, Inc. (0.02), greater than Entera Bio Ltd. (-9.15), greater than Tempest Therapeutics, Inc. (-0.66), less than Better Therapeutics, Inc. (-0.00), greater than Neoleukin Therapeutics, Inc. (-5.86), greater than Senti Biosciences, Inc. (-0.42), greater than Hillstream BioPharma, Inc. (-0.99), greater than Quoin Pharmaceuticals, Ltd. (-0.45),
Company | PE Ratio | Market cap |
---|---|---|
-0.39 | $2.18M | |
-0.85 | $13.07K | |
-6.68 | $45.76M | |
-1.57 | $45.93M | |
-0.85 | $3.74M | |
-0.01 | $85.44K | |
-0.54 | $35.05M | |
-0.37 | $5.99M | |
-0.93 | $42.09M | |
-0.41 | $9.85M | |
-0.68 | $24.53M | |
0.02 | $109.72K | |
-9.15 | $82.14M | |
-0.66 | $39.92M | |
-0.00 | $5.45K | |
-5.86 | $8.20M | |
-0.42 | $29.92M | |
-0.99 | $4.17M | |
-0.45 | $3.94M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Timber Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Timber Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Timber Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Timber Pharmaceuticals, Inc. (TMBR)?
What is the highest PE Ratio for Timber Pharmaceuticals, Inc. (TMBR)?
What is the 3-year average PE Ratio for Timber Pharmaceuticals, Inc. (TMBR)?
What is the 5-year average PE Ratio for Timber Pharmaceuticals, Inc. (TMBR)?
How does the current PE Ratio for Timber Pharmaceuticals, Inc. (TMBR) compare to its historical average?